Who are Quanterix Corporation's main suppliers?

Quanterix Corporation (QTRX) key suppliers include: Eli Lilly and Company, Eli Lilly and Company. View the full supplier network at chainsifter.com/chain/QTRX.

Who are Quanterix Corporation's major customers?

Quanterix Corporation (QTRX) key customers include: USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES, SIMOA, SPATIAL-BIOLOGY, Eli Lilly and Company, Eli Lilly and Company. View the full customer network at chainsifter.com/chain/QTRX.

What sector is Quanterix Corporation in?

Quanterix Corporation (QTRX) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

QTRX Supply Chain: Quanterix Corporation Suppliers & Customers

2Suppliers

5Customers

3Debt Items

20Related Chains

Quanterix Corporation Suppliers

Ticker	Name	Confidence	Evidence
LLY	Eli Lilly and Company	72%	accounted for greater than % of the Company’s total revenue. For the year ended December 31, 2023, customer of approximately $ million revenue accounted for greater than % of the Company’s total reve…
LLY	Eli Lilly and Company	72%	Reciprocal relationship from LLY graph: Reciprocal relationship from QTRX graph: accounted for greater than % of the Company’s total revenue. For the year ended December 31, 2023, customer of approxi…

Quanterix Corporation Customers

Ticker	Name	Confidence	Evidence
USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES	USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES	95%	USAspending awards from Department of Health and Human Services: $209,164 across 5 awards. 75N93021P00634 QUANTERIX SP-X ULTRA-SENSITIVE BIOMARKER DETECTION SYSTEM; 75N95024P00082 MAINTENANCE SERVICE…
SIMOA	SIMOA	92%	All of the Company's collaboration and license revenue was generated by Simoa technology.
SPATIAL-BIOLOGY	SPATIAL-BIOLOGY	92%	All of the Company's collaboration and license revenue was generated by Simoa technology.
LLY	Eli Lilly and Company	72%	nary shares of UltraDx with a deemed fair value of $ million. The issuance of the shares was contingent on UltraDx completing a preferred share financing under the terms and conditions in the UltraDx…
LLY	Eli Lilly and Company	72%	Reciprocal relationship from LLY graph: Reciprocal relationship from QTRX graph: nary shares of UltraDx with a deemed fair value of $ million. The issuance of the shares was contingent on UltraDx com…

Quanterix Corporation Debt Obligations

Instrument	Description	Confidence	Evidence
QTRX-DEBT	Debt stack $35.3M	90%	Market cache reports total debt of $35.3M.
QTRX-DEBT-12018	Warrants outstanding: 29000	90%	xbrl warrant detail from xbrl 2017-12-31.
QTRX-DEBT-12019	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2022-12-31.

Quanterix Corporation Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Quanterix Corporation.

Quanterix Corporation Ownership

Holder	Name	Confidence	Evidence
QTRX-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC	VANGUARD CAPITAL MANAGEMENT LLC	90%	13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 130 tracked holders.

Quanterix Corporation Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
LLY	Eli Lilly and Company	100.00	1	['customer', 'supplier']
SIMOA	SIMOA	63.48	1	['receiving']
DAWN	Day One Biopharmaceuticals Inc	50.00	2
BIOA	BioAge Labs, Inc.	50.00	2
FHTX	Foghorn Therapeutics Inc.	50.00	2
DSGN	Design Therapeutics, Inc.	50.00	2
EDSA	Edesa Biotech, Inc.	50.00	2
ELAN	Elanco Animal Health Incorporated	50.00	2
BCYC	Bicycle Therapeutics plc	50.00	2
LGND	Ligand Pharmaceuticals Incorporated	50.00	2
AMPH	Amphastar Pharmaceuticals, Inc.	50.00	2
NVO	Novo Nordisk A/S	50.00	2
GYRE	Gyre Therapeutics, Inc.	50.00	2
SDGR	Schrödinger, Inc.	50.00	2
ALNY	Alnylam Pharmaceuticals, Inc.	50.00	2
AKTS	Aktis Oncology, Inc.	50.00	2
CRNX	Crinetics Pharmaceuticals, Inc.	50.00	2
CAH	Cardinal Health, Inc.	50.00	2
ECOR	electroCore, Inc.	50.00	2
AXSM	Axsome Therapeutics, Inc.	50.00	2

Quanterix Corporation Supply Chain